NASDAQ:SPRY

Ars Pharmaceuticals Stock News

Healthcare > Biotechnology

Buy SPRY

*Your capital is at risk

$8.75

-0.150 (-1.69%)

At Close: Jun 03, 2026

The Schall Law Firm Begins Probe Into Claims Against ARS Pharmaceuticals Inc And Urges Affected Investors To Participate

04:00pm, Thursday, 20'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica

Allegations Against ARS Pharmaceuticals Inc Schall Law Firm Initiates Investigation And Encourages Impacted Investors To Get Involved

04:10pm, Wednesday, 19'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica

Allegations Against ARS Pharmaceuticals Inc The Schall Law Firm Initiates Investigation And Encourages Impacted Investors To Get Involved

04:30pm, Tuesday, 18'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica

Claims Against Ars Pharmaceuticals Inc Schall Law Firm Begins Probe And Urges Affected Investors To Participate

07:15pm, Monday, 17'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica

Allegations Against ARS Pharmaceuticals, Inc.: Schall Law Firm Initiates Investigation And Encourages Impacted Investors To Get Involved

06:00pm, Tuesday, 11'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica

Charges Against ARS Pharmaceuticals, Inc.: Schall Law Firm Launches Examination And Invites Affected Investors To Participate

11:00am, Sunday, 09'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical

Accusations Against ARS Pharmaceuticals, Inc.: Schall Law Firm Initiates Inquiry And Calls On Impacted Investors To Engage

11:00am, Saturday, 08'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical

Claims Against ARS Pharmaceuticals, Inc.: Schall Law Firm Begins Probe And Invites Affected Investors To Connect

04:30pm, Friday, 07'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical

Allegations Against ARS Pharmaceuticals, Inc.: Schall Law Firm Initiates Investigation And Encourages Impacted Investors To Reach Out

01:00pm, Thursday, 06'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical

ARS Pharmaceuticals, Inc. Allegations: Schall Law Firm Commences Examination and Calls on Affected Investors to Connect

01:45pm, Wednesday, 05'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical

The Schall Law Firm is commencing an examination into allegations against ARS Pharmaceuticals, Inc. and is calling on investors who have experienced losses to get in touch

03:30pm, Tuesday, 04'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical

SPRY INVESTIGATION PROGRESS REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

07:30pm, Monday, 03'rd Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical

IMPORTANT INVESTIGATION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

11:00am, Sunday, 02'nd Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical

IMPORTANT INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

11:00am, Saturday, 01'st Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical

IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

06:00pm, Friday, 31'st May 2024

LOS ANGELES, CA / ACCESSWIRE / May 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by